Explore the Future of Drug Pricing, Discuss Strategies to Maintain Compliance, and Evaluate the Financial Risks and Opportunities of the Program
The 4th Annual 340B Summit brings together HRSA grantees and covered entities to provide clarification and guidance for managing the 340B Drug Pricing Program. The summit analyzes the complex aspects of 340B, including determining the impact of policy changes, understanding best drug management and pharmacy contracting strategies, maintaining compliance with the program, and determining how to minimize risks and maximize opportunities for financial savings.
Pharmacy Credits - Pending Approval
Topics to be discussed in 2019 include:
- Impact of policy changes on 340B
- Collaboration with vendors
- Cost of non-adherence
- Proven strategies to maintain compliance
- Audit preparation
- Engaging physicians with the program
- Working with contract pharmacies
- And more!
Feedback From Past Summits:
Overall good experience and gained knowledge from everyone who attended! Great networking opportunity.
–Bhupinder Kaur, 340B Analyst, San Mateo Medical Center
I was very satisfied with the summit and the presenters. Great topics, good information. Better than (other meetings) I have attended. Great take home points.
–James E. Dice, Director of Pharmacy, Children's Hospital Pharmacy
I honestly did not know what to expect and prayed it was not a waste of time. I was completely shocked by how good this conference was. One of the BEST I have ever attended.
– a 2016 attendee
Great 1st meeting - looking forward to more conferences to come.
– David Neu, Executive Director of Pharmacy, Saint Thomas Health
This was my first World Congress. I will look for others. The info is very timely, thorough with impressive speakers.
– Donna Goodman, VP and CFO/COO, Westside Family Healthcare
Good information, excellent experience, close to home.
– Melissa Yeany, 340B Compliance Officer, Northwest Alliance
Great avenue for connecting with other 340B Entities. Found experiences of others to be very educational. Emphasis on areas that we weren't looking at. Recognized need to review and document savings. Great ideas on how to accomplish this task.
–Barb Doty, Pharma Business Manager, St. Croix Regional Medical Center
I am impressed with the knowledge of presenters and learned a lot that will benefit our program.
–Buhari Mohammed, MD, MBA, Director of Regional Operations, Primary One Health
Call for Papers
Submit Abstract for Presentations
The 4th Annual Covered Entities’ 340B Summit is now accepting abstract submissions for 2019!